Another Great Report by Analysts at Haywood Cap MktsI cant copy / paste the contents of the full report, but here's the "Recommended Action":
"We reiterate our Buy recommendation and $7.00 target price. We view Valens as an attractive investment in the cannabis sector as the market evolves toward extracted and consumer products. We believe the shares of Valens Groworks are undervalued trading at 7.4x our F2020 EV / EBITDA estimate versus large cap Canadian peers at 23.1x and small cap Canadian peers at 12.4x."